Thomas J. Schall - 11 Mar 2024 Form 4 Insider Report for Immuneering Corp (IMRX)

Role
Director
Signature
/s/ Michael D. Bookman, Attorney-in-Fact for Thomas J. Schall
Issuer symbol
IMRX
Transactions as of
11 Mar 2024
Net transactions value
$0
Form type
4
Filing time
12 Mar 2024, 17:02:16 UTC
Previous filing
24 Oct 2022
Next filing
25 Mar 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMRX Stock Option Award $0 +35,000 $0.000000 35,000 11 Mar 2024 Class A Common Stock 35,000 $5.93 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable in equal monthly installments over a three year period commencing on April 11, 2024, and will be fully vested and exercisable on March 11, 2027.